Maria A. Rodriguez
<p>My research interests are in the filed of internetional cardiology and include acute coronary care and stent restenosis. Other interests include gender differences in the management of cardiovascular disease. </p>
Judah N. Rauch
<span style="color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, 'Courier New', monospace;font-size:16px;background-color:#ffffff;">Dr. Rauch's clinical focus is on the treatment of patients with coronary artery disease. He has a particular interest in the care of patients with acute coronary syndromes, cardiogenic shock and complex coronary disease.</span>
<p><span style="color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, 'Courier New', monospace;font-size:16px;background-color:#ffffff;">Dr. Rauch’s research builds on his clinical interests and is focused on bringing large, multi-site clinical trials to Montefiore, affording patients the opportunity to benefit from new and innovative therapies.</span></p>
<p>Judah Nathaniel Rauch, MD, is an Interventional Cardiologist at Montefiore and Assistant Professor of Clinical Medicine at our Albert Einstein College of Medicine. His clinical focus is on the treatment of patients with coronary artery disease. He has a particular interest in the care of patients with acute coronary syndromes, cardiogenic shock and complex coronary disease.</p><p>Dr. Rauch earned his Bachelor of Arts at Yeshiva University in 2006, followed by his Doctor of Medicine at New York University School of Medicine in 2010. He began his postdoctoral training at New York’s Mount Sinai Hospital, completing a residency in internal medicine in 2013, serving as chief resident in 2014 and completing a fellowship in cardiovascular disease in 2017. In 2018, he completed an interventional cardiology fellowship at Montefiore Medical Center; he received his Master of Business Administration from the University of Massachusetts in the same year.</p><p>Dr. Rauch’s research builds on his clinical interests and is focused on bringing large, multi-site clinical trials to Montefiore, affording patients the opportunity to benefit from new and innovative therapies.</p><p>Dr. Rauch is board certified in interventional cardiology, cardiovascular disease and internal medicine by the American Board of Internal Medicine.</p>
Stuart W. Moser
E. Scott Monrad
Dr. Monrads' clinical focus is on interventional cardiology, hemodynamic assessment of valvular heart disease and hemodynamic assessment of congestive heart failure. He also has an interest in preventive cardiology in outpatients.
Dr. Monrad’s research focuses on improving clinical outcomes in patients with coronary artery disease.
<p>E. Scott Monrad, MD, CM, is Training Program Director, Cardiovascular Diseases; Director of Cardiovascular Quality; and Vice Chief of Cardiology, Patient Safety and Quality at Montefiore. He is also Professor of Clinical Medicine at our Albert Einstein College of Medicine. His clinical focus is on interventional cardiology, hemodynamic assessment of valvular heart disease and hemodynamic assessment of congestive heart failure. He also has an interest in preventive cardiology in outpatients.</p><p>After receiving his Bachelor of Arts from Harvard University in 1975, Dr. Monrad went on to receive his Doctor of Medicine and Master of Surgery in 1979 from McGill University Medical School in Montreal, Quebec. He attended New England Medical Center Hospital for the start of his postdoctoral training, completing an internship in medicine in 1980, and a residency in 1982. From 1982 to 1985, he was a fellow in the cardiovascular division at the Harvard Beth Israel Hospital in Boston, and from 1985 to 1986, he was a research fellow with the cardiology department at Medizinische Poliklinik, Universitaetsspital in Zurich, Switzerland.</p><p>Dr. Monrad’s research focuses on improving clinical outcomes in patients with coronary artery disease. His research findings have been published in many reviewed journals and abstracts. He has also contributed to many books.</p><p>Dr. Monrad has been included in Castle Connolly Top Doctors. He is board certified and is a member of several professional associations.</p>
Mark A. Menegus
<span style="background-color:#ffffff;"><span style="color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, Courier New, monospace;"><span style="font-size:16px;">Dr. Menegus's clinical focus has been interventional and clinical cardiology, interventional management of acute myocardial infarction, acute coronary syndromes, outpatient consultative cardiology and training general and interventional cardiology fellows.</span></span></span>
<span style="color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, 'Courier New', monospace;font-size:16px;background-color:#ffffff;">Dr. Menegus has been the Principal Investigator for many research projects, including the NIH-sponsored Myocardial Infarction and Transfusion trial, the SHOCK trial, and the PHRI-sponsored COMPLETE trial.</span>
<p>Mark A. Menegus, MD, FACC, FSCAI, is Director of Cardiac Catheterization Laboratory at Montefiore’s Einstein campus and Professor of Medicine at Albert Einstein College of Medicine. Since joining Montefiore, his focus has been interventional and clinical cardiology, interventional management of acute myocardial infarction, acute coronary syndromes, outpatient consultative cardiology and training general and interventional cardiology fellows.</p><p>In 1977, Dr. Menegus received his Bachelor of Arts in Biological Science/Physiology from Rutgers University. He then attended Rutgers Medical School, where he received his Doctor of Medicine in 1981. From 1981 to 1987, Dr. Menegus completed an internship and residency in internal medicine and a fellowship in cardiology at Montefiore, also serving as an Assistant Firm Leader in the Deparment of Medicine.</p><p>Dr. Menegus has been the Principal Investigator for many research projects, including the NIH-sponsored Myocardial Infarction and Transfusion trial, the SHOCK trial, and the PHRI-sponsored COMPLETE trial. His work has been published in peer-reviewed journals, books and abstracts and has been presented nationally.</p><p>He is board certified by the American Board of Internal Medicine and is a member of numerous professional societies, including the American College of Cardiology, the Society for Cardiac Angiography and Intervention and the American Heart Association. Dr. Menegus has been listed in Castle Connolly Medical as a New York Metro Area Top Doctor from 2001 to 2019. </p>
Mohamed Azeem Latib
Dr. Latib is a world-leading expert in interventional cardiology, with a clinical focus on complex coronary interventions as well as transcatheter aortic, mitral and tricuspid interventions.
Following from his clinical interests, Dr. Latib’s research centers on transcatheter aortic, mitral and tricuspid interventions with a focus on device innovation. In addition, he performs research on drug-coated balloons, drug-eluting stents and challenging lesion subsets.
<p>Azeem Latib, MB BCh, is Medical Director of Structural Heart Interventions at Montefiore. Dr. Latib is a world-leading expert in interventional cardiology, with a clinical focus on complex coronary interventions as well as transcatheter aortic, mitral and tricuspid interventions. He has extensive clinical experience in TAVR and MitraClip, as well as expertise in novel and new devices to treat mitral and tricuspid valve disease minimally invasively without open-heart surgery.</p><p>In 1995, Dr. Latib received his Bachelor of Medicine at the University of Witwatersrand in Johannesburg, South Africa. He completed a fellowship with the College of Physicians of South Africa in 2002, followed by a certificate in cardiology from the same institution in 2005. In 2008 he completed a master’s in interventional cardiology at San Raffaele Scientific Institute and University Vita Salute in Milan, Italy. In 2018, he attended the University of Zurich to earn a certificate of advanced studies in aortic structural interventions.</p><p>Following from his clinical interests, Dr. Latib’s research centers on transcatheter aortic, mitral and tricuspid interventions with a focus on device innovation. In addition, he performs research on drug-coated balloons, drug-eluting stents and challenging lesion subsets. His findings have been published widely, with more than 550 peer-reviewed publications. Dr. Latib serves on the editorial board for many journals, including <em>Cardiac Interventions Today</em>, the <em>Journal of the American College of Cardiology,</em> <em>Cardiovascular Interventions</em> and <em>Cardiovascular Revascularization Medicine</em>. He is a reviewer for many more journals and serves on the faculty of several international conferences.</p><p>Dr. Latib is a member of several professional organizations, including the American College of Cardiology and the European Society of Cardiology.</p>
Anna Kezerashvili
Nils A. Guttenplan
<p>Dr. Guttenplan is committed to improving the patient's quality of life and prognosis across the spectrum of heart rhythm disorders. All contemporary approaches including pacemakers, defibrillators, catheter ablations, and left atrial appendage occlusion devices are drawn upon to achieve this aim.</p>
<p>Dr. Guttenplan is the principle investigator at Montefiore in an outcomes study of a left ventricular quadrapolar pacing lead. During the study he as adapted the use of an interventional snare technique. This approach has allowed for successful left ventricular lead placement, that would not have been possible with the conventional approach. Dr. Guttenplan is also a co-investigator in the division's ablation studies.</p>
<p>Nils A. Guttenplan, MD, is an Attending Physician in the Cardiology Department at Montefiore. His clinical focus is improving the patient's quality of life and prognosis across the spectrum of heart rhythm disorders. He has an interest in all contemporary approaches to achieve this aim, including pacemakers, defibrillators, catheter ablations, and left atrial appendage occlusion devices. Dr. Guttenplan joined the Montefiore team in 2018.</p><p>Dr. Guttenplan attended New York Medical College where he received his Doctor of Medicine. In 2004, Dr. Guttenplan completed a residency in Internal Medicine at St. Vincent?s Medical Center. He completed a fellowship in Cardiovascular Disease at our Albert Einstein College of Medicine, followed by a fellowship in Clinical Cardiac Electrophysiology at New York University.</p><p>Dr. Guttenplan is the Principal Investigator in a study on left ventricular quadripolar pacing lead. During the study, he has developed the use of an interventional snare technique that has allowed for successful left ventricular lead placement that would not have been possible with the conventional approach. Dr. Guttenplan is also a co-Investigator in the division's ablation studies. His work has been published in numerous peer-reviewed journals.</p>
Jay N. Gross
<p>Dr. Gross specializes in complex electrophysiology (EP) management problems as well as issues related to implantation and management of all types of implantable electrical devices, with a focus on lead extraction.</p>
<p>Dr. Gross has been a principal site or co-investigator in many of the critical clinical trials that have established the utility and indications for pacemaker mode selection, rate modulated pacing, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy. Most recently, he has been involved in studies designed to define the role of temporary external defibrillator systems and the safety of implantable devices in the magnetic resonance imaging (MRI) setting. He has also been principal or co-author of dozens of scientific publications.</p>
<p>Jay N. Gross, MD, serves as an Attending Physician and Director of the Implantable Electrical Devices Service at Montefiore, as well as Professor of Medicine (Cardiology) at our <a href="http://www.einstein.yu.edu/faculty/2274/jay-gross/" rel="noopener noreferrer" target="_blank">Albert Einstein College of Medicine</a>. His clinical focus is on complex electrophysiology (EP) management problems as well as issues related to implantation and management of all types of implantable electrical devices, with a focus on lead extraction.</p><p>After graduating from our Albert Einstein College of Medicine, and completing his residency at Montefiore in Internal Medicine, Dr. Gross continued on to complete a cardiology fellowship at Montefiore. <br /><br />Dr. Gross has been a principal site or co-investigator in many of the critical clinical trials that have established the utility and indications for pacemaker mode selection, rate-modulated pacing, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy. Most recently, he has been involved in studies designed to define the role of temporary external defibrillator systems and the safety of implantable devices in the magnetic resonance imaging (MRI) setting. He has also been principal or co-author of dozens of scientific publications.</p><p>Recent clinical highlights for Dr. Gross include: the first reported cases of implantation of subcutaneous ICDs in heart transplant patients, simultaneous lead extraction and debulking of large vegetations in patients with endocarditis, concomitant lead extraction and implantation of leadless pacemakers, and care for of congenital heart patients who require both transvenously implanted devices and subcutaneous ICDs.</p><p>Dr. Gross is board certified in Internal Medicine, Cardiology, and Cardiovascular Electrophysiology as well as a Certified Cardiac Device Specialist (CCDS) by the International Board of Heart Rhythm Examiners. He is a Fellow of the American College of Cardiology and a member of the Heart Rhythm Society. Dr. Gross has served on the Writing Committee of the International Board of Heart Rhythm Board of Examiners for over two decades and now serves on its board of directors. He has been named to the Castle Connolly/NY Magazine List of Best EP Doctors in New York for the past two years.</p>